In this issue:
Anti-TNF therapy for early-stage Dupuytren’s disease
ACTH vs steroids for the treatment of acute gout
Baricitinib for relapsing GCA
Baricitinib decreases anti-dsDNA in patients with SLE
Factors predicting axSpA among first-degree relatives of ankylosing spondylitis patients
Intensive serum urate lowering therapy for erosive gout
Knee and hip OA and risk of cancer
Nintedanib in patients with autoimmune disease-related progressive fibrosing ILDs
Tocilizumab for new onset PMR
Tofacitinib and risk of CV outcomes
Please login below to download this issue (PDF)